Literature DB >> 31532375

[LAP (LC3-associated phagocytosis): phagocytosis or autophagy?]

Mathilde Galais1, Baptiste Pradel1, Isabelle Vergne2, Véronique Robert-Hebmann1, Lucile Espert1, Martine Biard-Piechaczyk1.   

Abstract

Phagocytosis and macroautophagy, named here autophagy, are two essential mechanisms of lysosomal degradation of diverse cargos into membrane structures. Both mechanisms are involved in immune regulation and cell survival. However, phagocytosis triggers degradation of extracellular material whereas autophagy engulfs only cytoplasmic elements. Furthermore, activation and maturation of these two processes are different. LAP (LC3-associated phagocytosis) is a form of phagocytosis that uses components of the autophagy pathway. It can eliminate (i) pathogens, (ii) immune complexes, (iii) threatening neighbouring cells, dead or alive, and (iv) cell debris, such as POS (photoreceptor outer segment) and the midbody released at the end of mitosis. Cells have thus optimized their means of elimination of dangerous components by sharing some fundamental elements coming from the two main lysosomal degradation pathways.
© 2019 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31532375     DOI: 10.1051/medsci/2019129

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

Review 1.  Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk.

Authors:  Gaigai Li; Prativa Sherchan; Zhouping Tang; Jiping Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 2.  Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis.

Authors:  Yu-Chen Meng; Xiao-Li Lou; Li-Yuan Yang; Dong Li; Yan-Qiang Hou
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-10       Impact factor: 4.553

Review 3.  Regulation of Innate Immune Responses by Autophagy: A Goldmine for Viruses.

Authors:  Baptiste Pradel; Véronique Robert-Hebmann; Lucile Espert
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.